These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12151123)

  • 1. Antiepileptic drugs to prevent neural degeneration associated with epilepsy: assessing the prospects for neuroprotection.
    Sutula T
    Epilepsy Res; 2002 Jun; 50(1-2):125-9. PubMed ID: 12151123
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.
    Pitkänen A
    Epilepsy Res; 2002 Jun; 50(1-2):141-60. PubMed ID: 12151125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection and antiepileptogenesis: where are we now?
    Dichter MA; Cole AJ
    Neurology; 2002 Nov; 59(9 Suppl 5):S36-8. PubMed ID: 12428031
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate and neuroprotection.
    Vajda FJ
    J Clin Neurosci; 2002 Sep; 9(5):508-14. PubMed ID: 12383405
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiepileptic drugs and neuroprotection: current status and future roles.
    Willmore LJ
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection possibilities in epileptic children.
    Artemowicz B; Sobaniec W
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():91-5. PubMed ID: 16119636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tiagabine--own experience in the refractory epilepsy treatment].
    Błaszczyk B
    Wiad Lek; 2013; 66(2 Pt 2):175-9. PubMed ID: 25775813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection in epilepsy: the Holy Grail of antiepileptogenic therapy.
    Sankar R
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S1-2. PubMed ID: 16243002
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiepileptic drugs in neuroprotection.
    Pitkänen A; Kubova H
    Expert Opin Pharmacother; 2004 Apr; 5(4):777-98. PubMed ID: 15102563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazepam and pentobarbital protect against scorpion venom toxin-induced epilepsy.
    Luongo R; Oliveira DA; Lebrun I; Sandoval MR
    Brain Res Bull; 2009 Jun; 79(5):296-302. PubMed ID: 19393725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multimodal prospects for neuroprotection and disease modification in epilepsy: relationship to its challenging neurobiology.
    Hamed SA
    Restor Neurol Neurosci; 2010; 28(3):323-48. PubMed ID: 20479527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection and antiepileptogenesis: overview, definitions, and context.
    Cole AJ; Dichter M
    Neurology; 2002 Nov; 59(9 Suppl 5):S1-2. PubMed ID: 12428024
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic potential of thyreoliberin (TRH) and its analogues as antiepileptic and neuroprotective drugs].
    Jantas D
    Przegl Lek; 2010; 67(11):1179-85. PubMed ID: 21442973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection and epilepsy.
    Halász P; Rásonyi G
    Adv Exp Med Biol; 2004; 541():91-109. PubMed ID: 14977210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to anticonvulsant drug discovery.
    Miziak B; Chrościńska-Krawczyk M; Błaszczyk B; Radzik I; Czuczwar SJ
    Expert Opin Drug Discov; 2013 Nov; 8(11):1415-27. PubMed ID: 24050182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroprotective activity of antiepileptic drugs].
    Czuczwar K; Czuczwar M; Cieszczyk J; Gawlik P; Luszczki JJ; Borowicz KK; Czuczwar SJ
    Przegl Lek; 2004; 61(11):1268-71. PubMed ID: 15727029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of GluR2/GAPDH Complex Interaction by TAT-GluR2
    Mi Q; Yao G; Zhang GY; Zhang J; Wang J; Zhao P; Liu J
    Ann Clin Lab Sci; 2018 Jul; 48(4):460-468. PubMed ID: 30143487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.